Natco Pharma Ltd
Rajubabu Kollu is a seasoned professional with extensive experience in quality assurance and compliance within the pharmaceutical industry. Currently serving as Manager of Global Corporate Quality Assurance at NATCO Pharma since December 2023, Rajubabu oversees compliance in manufacturing, quality assurance, and microbiology for sterile formulation facilities. Previously, Rajubabu held a leadership position at Dr. Reddy's Laboratories, where responsibilities included leading site investigations and managing quality systems. With a foundational career at Aurobindo Pharma, Rajubabu gained expertise in site investigations and quality risk management, handling critical quality assessments and investigations across multiple pharmaceutical operations. Rajubabu has also contributed to quality management systems at Mylan, Shantha Biotechnics, Hospira, and Bharat Biotech, demonstrating a solid background in regulatory compliance, training, and documentation management. Educational qualifications include a Master of Science in Microbiology and various certifications in quality assurance, regulatory affairs, and environmental health and safety management.
This person is not in any offices
Natco Pharma Ltd
2 followers
Natco Pharma Limited is a pharmaceutical company. The Company is engaged in developing, manufacturing and marketing finished dosage formulations (FDF) and active pharmaceutical ingredients (APIs). The Company's segments include active pharmaceuticals ingredient, finished dosage formulations, job works, pharmacy and others. The Company's product categories include Domestic Formulations, International Formulations, API's and Blockbusters. The Company's products include Alphalan, Bandrone, Bendit, Clokeran, Lenalid, Thioplan, Anastronat, Capnat, Fulvenat, Kabanat, Natdox-LP, Rapact, Temonat, X-Trant, Glatimer, Hepcinat, Natdac, Natzold, Tigi, Alprazolam, Chloroquine Phosphate, Lansoprazole, Letrozole, Granisetron, Rizatriptan IR, Imatinib, Salmeterol Xinafoate, Sertraline Form I, Ibandronate Sodium Monohydrate, Pantoprazole Sodium Sesquihydrate, Ondansetron Hydrochloride (Injectable Grade), Daclatasvir and Glatiramer Acetate. The Company manufactures over 20 products under contract.